Tryptophan hydroxylase immunoreactivity is altered by the genetic variation in postmortem brain samples of both suicide victims and controls

Molecular Psychiatry

Volumn 7, Issue 10, 2002, Pages 1127-1132

  Ono, H ^a   Shirakawa, O ^a   Kitamura, N ^b   Hashimoto, T ^a   Nishiguchi, N ^a   Nishimura, A ^c   Nushida, H ^a   Ueno, Y ^a   Maeda, K ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Polymorphism; Postmortem brain study; Receptor binding assay; Serotonin 2A receptor (5HT2A receptor); Suicide; Tryptophan hydroxylase (TPH); Western blot

Indexed keywords

SEROTONIN 2A RECEPTOR; TRYPTOPHAN HYDROXYLASE;

ADULT; ARTICLE; AUTOPSY; BEHAVIOR; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR DENSITY; SAMPLING; SEROTONINERGIC SYSTEM; SUICIDE;

HUMANS; POSTMORTEM CHANGES; SUICIDE; TRYPTOPHAN HYDROXYLASE; VARIATION (GENETICS);

EID: 0036927649     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001150     Document Type: Article

References (33)

1. Mann JJ, Oquendo M, Underwood MD, Arango V. The neurobiology of suicide risk: A review for the clinician. J Clin Psychiatry 1999; 2: 7-11.
2. Asberg M, Traskman L, Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 1976; 33: 1193-1197.
3. Mann JJ, Malone KM. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Biol Psychiatry 1997; 41: 162-171.
4. Quattrone A, Tedeschi G, Aguglia U, Scopacasa F, Direnzo GF, Annunziato L. Prolactin secretion in man: A useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine. Br J Clin Pharmacol 1983; 16: 471-475.
5. Malone KM, Corbitt EM, Li S, Mann JJ. Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br J Psychiatry 1996; 168: 324-329.
6. Arango V, Underwood MD, Mann JJ. Postmortem findings in suicide victims. Implications for in vivo imaging studies. Ann N Y Acad Sci 1997; 836: 269-287.
7. Arango V, Ernsberger P, Marzuk PM, Chen JS, Tierney H, Stanley M et al. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 1990; 47: 1038-1047.
8. Hrdina PD, Demeter E, Vu TB, Sotonyi P, Palkovits M. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: Increase in 5-HT2 sites in cortex and amygdala. Brain Res 1993; 614: 37-44.
9. Du L, Faludi G, Palkovits M, Demeter E, Bakish D, Lapierre YD et al. Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims. Biol Psychiatry 1999; 46: 196-201.
10. Roy A, Segal NL, Centerwall BS, Robinette CD. Suicide in twins. Arch Gen Psychiatry 1991; 48: 29-32.
11. Wender PH, Kety SS, Rosenthal D, Schulsinger F, Ortmann J, Lunde I. Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders. Arch Gen Psychiatry 1986; 43: 923-929.
12. Turecki G, Briere R, Dewar K, Antonetti T, Lesage AD, Seguin M et al. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am J Psychiatry 1999; 156: 1456-1458.
13. Kouzmenko AP, Scaffidi A, Pereira AM, Hayes WL, Copolov DL, Dean B. No correlation between A (-1438) G polymorphism in 5-HT2A receptor gene promoter and the density of frontal cortical 5-HT2A receptors in schizophrenia. Hum Hered 1999; 49: 103-105.
14. Spurlock G, Heils A, Holmans P, Williams J, D'Souza UM, Cardno A et al. A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter. Mol Psychiatry 1998; 3: 42-49.
15. Du L, Bakish D, Lapierre YD, Ravindran AV, Hrdina PD. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Am J Med Genet 2000; 96: 56-60.
16. Bondy B, Kuznik J, Baghai T, Schule C, Zwanzger P, Minov C et al. Lack of association of serotonin-2A receptor gene polymorphism (T102C) with suicidal ideation and suicide. Am J Med Genet 2000: 96: 831-835.
17. Ono H, Shirakawa O, Nishiguchi N, Nishimura A, Nushida H, Ueno Y, Kiyoshi Maeda K. Serotonin 2A receptor gene polymorphism is not associated with completed suicide. J Psychiatr Res 2001: 35: 173-176.
18. Nielsen DA, Goldman D, Virkkunen M, Tokola R, Rawlings R, Linnoila M. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch Gen Psychiatry 1994; 51: 34-38.
19. Mann JJ, Malone KM, Nielsen DA, Goldman D, Erdos J, Gelernter J. Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients. Am J Psychiatry 1997; 154: 1451-1453.
20. Bellivier F, Leboyer M, Courtet P, Buresi C, Beaufils B, Samolyk D et al. Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch Gen Psychiatry 1998; 55: 33-37.
21. Kunugi H, Ishida S. Kato T, Sakai T, Tatsumi M, Hirose T, Nanko S. No evidence for an association of polymorphisms of the tryptophan hydroxylase gene with affective disorders or attempted suicide among Japanese patients. Am J Psychiatry 1999; 156: 774-776.
22. Rotondo A, Schuebel K, Bergen A, Aragon R, Virkkunen M, Linnoila M et al. Identification of four variants in the tryptophan hydroxylase promoter and association to behavior. Mol Psychiatry 1999; 4: 360-368.
23. Ono H, Shirakawa O, Nishiguchi N, Nishimura A, Nishida H, Ueno Y, Maeda K. Tryptophan hydroxylase gene polymorphisms are not associated with suicide. Am J Med Genetics 2000; 96: 861-863.
24. Abbar M, Courtet P, Bellivier F, Leboyer M, Boulenger JP, Castelhau D et al. Suicide attempts and the tryptophan hydroxylase gene. Mol Psychiatry 2001; 6: 268-273.
25. Turecki G, Tzemova J, Lesage A, Seguin M, Tousignant M, Chawky N et al. TPH and suicidal behavior: A study in suicide completers. Mol Psychiatry 2001; 6: 98-102.
26. Cash CD, Vayer P, Mandel P, Maitre M. Tryptophan 5-hydroxylase. Rapid purification from whole rat brain and production of a specific antiserum. Eur J Biochem 1985; 149: 239-245.
27. Yu PL, Fujimura M, Okumiya K, Kinoshita M, Hasegawa H, Fujimiya M. Immunohistochemical localization of tryptophan hydroxylase in the human and rat gastrointestinal tracts. J Comp Neurol 1999; 411: 654-665.
28. Nielsen DA, Jenkins GL, Stefanisco KM, Jefferson KK, Goldman D. Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron. Mol Brain Res 1997; 45: 145-148.
29. Perry EK, Perry RH, Tomlinson BE. The influence of agonal status on some neurochemical activities of postmortem human brain tissue. Neurosci Lett 1982; 29: 303-307.
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
31. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
32. Mita T, Hanada S, Nishino N, Kuno T, Nakai H, Yamadori T, Mizoi Y, Tanaka C. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics. Biol Psychiatry 1986; 21: 1407-1414.
33. Collier DA, Arranz MJ, Li T, Mupita D, Brown N, Treasure J. Association between 5-HT2A gene promoter polymorphism and anorexia nervosa. The Lancet 1997; 350: 412.